These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS. Abdom Radiol (NY); 2017 Feb; 42(2):577-584. PubMed ID: 27665482 [Abstract] [Full Text] [Related]
32. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma. Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, Kim YK. Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273 [Abstract] [Full Text] [Related]
39. Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1. Salamon J, Derlin T, Bannas P, Busch JD, Herrmann J, Bockhorn M, Hagel C, Friedrich RE, Adam G, Mautner VF. Eur J Nucl Med Mol Imaging; 2013 May; 40(5):685-92. PubMed ID: 23232507 [Abstract] [Full Text] [Related]
40. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study. Nishida Y, Ikuta K, Ito S, Urakawa H, Sakai T, Koike H, Ito K, Imagama S. Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]